GU (Genito-Urinary) BioBank

This facility is a central resource which houses annotated and high quality blood and urine specimens obtained from consenting patients. Led by Dr. Neil Fleshner

Overview
Under the leadership of Dr. Neil Fleshner, The UHN GU (Genito-Urinary) BioBank is a central resource which houses annotated and high quality blood and urine specimens obtained from consenting patients who have attended out-patient clinics within the GU division for the suspicion, diagnosis and/or treatment of a GU tumor (Prostate, Kidney, Bladder, Testis, Penis). These archived specimens are used in future research studies that aim to increase our understanding of urologic diseases (in particular cancer) and discover new ways of diagnosing and managing disease.
Services & Unique Capabilities
a)    Provision of retrospectively collected specimens (plasma, serum, buffy coat, urine) and/or data for REB-approved research
b)    Prospective collection services 
c)    Study-directed banking services
d)    Protocol and SOP development services
Using the Facility
For Services a through c listed in the 'Services and Unique Capabilities section', simply submit your request via the CAPCR system at UHN. For all other services or inquiries, contact the GU BioBank Manager directly. Note, an executed Materials Transfer Agreement is required for all external collaborations. Please inquire regarding applicable fees for the service of interest. 
Contacts
Karen Chadwick, MSc., CCRP
Clinical Research Manager
GUBioBank, Prostate and Uro-Oncology Clinical Research Unit
Princess Margaret Cancer Centre, University Health Network
610 University Ave., Room 3-202, Toronto, ON, M5G 2M9
Tel. 416-946-4501 x 5259  I  Mob. 647-404-2745  I  Fax. 416-946-2850
 

This facility is a central resource which houses annotated and high quality blood and urine specimens obtained from consenting patients. Led by Dr. Neil Fleshner

Overview
Under the leadership of Dr. Neil Fleshner, The UHN GU (Genito-Urinary) BioBank is a central resource which houses annotated and high quality blood and urine specimens obtained from consenting patients who have attended out-patient clinics within the GU division for the suspicion, diagnosis and/or treatment of a GU tumor (Prostate, Kidney, Bladder, Testis, Penis). These archived specimens are used in future research studies that aim to increase our understanding of urologic diseases (in particular cancer) and discover new ways of diagnosing and managing disease.
Services & Unique Capabilities
a)    Provision of retrospectively collected specimens (plasma, serum, buffy coat, urine) and/or data for REB-approved research
b)    Prospective collection services 
c)    Study-directed banking services
d)    Protocol and SOP development services
Using the Facility
For Services a through c listed in the 'Services and Unique Capabilities section', simply submit your request via the CAPCR system at UHN. For all other services or inquiries, contact the GU BioBank Manager directly. Note, an executed Materials Transfer Agreement is required for all external collaborations. Please inquire regarding applicable fees for the service of interest. 
Contacts
Karen Chadwick, MSc., CCRP
Clinical Research Manager
GUBioBank, Prostate and Uro-Oncology Clinical Research Unit
Princess Margaret Cancer Centre, University Health Network
610 University Ave., Room 3-202, Toronto, ON, M5G 2M9
Tel. 416-946-4501 x 5259  I  Mob. 647-404-2745  I  Fax. 416-946-2850